Context Therapeutics shares #ASCO23 data on CLDN-6 targeted treatments and CTIM-76 update

By Proactive Investors / June 13, 2023 / www.youtube.com / Article Link


Context Therapeutics CEO Marty Lehr joins Natalie Stoberman from the Proactive studios to discuss the latest data on clinical ...

Recent News

Market still expecting strong growth for major gold producers
July 27, 2026 / www.canadianminingreport.com

Newmont starts Q2/26 strong, growth expected for gold majors
July 27, 2026 / www.canadianminingreport.com

Gold not the consensus play anymore
July 20, 2026 / www.canadianminingreport.com

Gold stocks drop to lowest levels this year
July 20, 2026 / www.canadianminingreport.com

A rebalancing of gold's ratios versus major commodities
July 14, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok